a) Pfizer
b) Moderna
c) J&J
d) AstraZeneca
The United States Food and Drug Administration is likely to authorize the use of the COVID-19 vaccine of Pfizer for young adults of age 12 and older by the next week. The government aims at setting up shots for many before the beginning of the next school year.